DCF — USMD HOSPITAL OF ARLINGTON
Enterprise Value: $-48.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-48.3M
Enterprise Value
$-16.2M
PV of Cash Flows
$-32.2M
PV of Terminal Value
$-51.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $56.3M | $-2.5M | -5.0% | $-4.9M | $-4.5M |
| Year 2 | $58.0M | $-2.0M | -4.0% | $-4.5M | $-3.7M |
| Year 3 | $59.7M | $-1.5M | -3.0% | $-4.0M | $-3.0M |
| Year 4 | $61.5M | $-1.2M | -2.0% | $-3.8M | $-2.6M |
| Year 5 | $63.3M | $-1.1M | -2.0% | $-3.8M | $-2.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-48.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$54.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000004575148506
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5